EPISODE · Jun 27, 2023 · 12 MIN
[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market
from China Stories
Multinational pharmaceutical firms are changing strategies and selling business lines, as a government bulk-buying program favors cheaper, local products.Click here to read the article by Tang Hanyu and Kelly Wang.Narrated by Elyse Ribbons.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
What this episode covers
Multinational pharmaceutical firms are changing strategies and selling business lines, as a government bulk-buying program favors cheaper, local products.
NOW PLAYING
[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m